The Traderszone Network

31 August, 2016 by The TZ Newswire Staff Comments Off on How Atlas, Westbrook pulled off the St. John’s Terminal deal

How Atlas, Westbrook pulled off the St. John’s Terminal deal

Westbrook Partners and Atlas Capital Group are redeveloping the St. John’s Terminal into a 1.7 million-square-foot megaproject with more than 1,500 residential units. Last year, the partners struck a deal to pay $100 million for air rights over Pier 40 in Hudson River Park. A new investigation from DNAinfo reveals how exactly that deal went down, and what role top city officials including First Deputy Mayor Anthony Shorris and Deputy Mayor Alicia Glen played.

read more

31 August, 2016 by The TZ Newswire Staff Comments Off on Why Chico’s FAS, Inc. Stock Popped Today

Why Chico’s FAS, Inc. Stock Popped Today

Chicos Fas And Brands Logo

Image source: Chico’s FAS, Inc.

Shares of Chico’s FAS Inc. (NYSE: CHS) were up 12.4% as of 3:15 p.m. EDT Wednesday after the specialty retailer announced stronger-than-expected fiscal second-quarter 2016 results and new initiatives focusing on cost reduction and operational efficiency.

read more

31 August, 2016 by The TZ Newswire Staff Comments Off on How Much Should You Spend on an Engagement Ring?

How Much Should You Spend on an Engagement Ring?

The history and popular perception of engagement rings runs counter to the surprising correlation between ring cost and marriage success.

31 August, 2016 by The TZ Newswire Staff Comments Off on Leon Cooperman reveals the 5 ways he tries to make money in the market

Leon Cooperman reveals the 5 ways he tries to make money in the market

Leon Cooperman, chairman and CEO of Omega Advisors, revealed his five key principles for making money on the stock market.

31 August, 2016 by The TZ Newswire Staff Comments Off on If I Were a Valeant Pharmaceuticals Shareholder, This Would Infuriate Me

If I Were a Valeant Pharmaceuticals Shareholder, This Would Infuriate Me

Businessman Losing Money Stacked Coins Getty
Image source: Getty Images.

Drugmaker Valeant Pharmaceuticals (NYSE: VRX) has had a really rough go of things over the past year. Since peaking at approximately $264 a share last summer, shares of the once nearly megacap company have fallen back into mid-cap status.

read more

31 August, 2016 by The TZ Newswire Staff Comments Off on The 21st century’s greatest films form a stark contrast to the highest earners

The 21st century’s greatest films form a stark contrast to the highest earners

A film deemed a great work by critics may not earn its keep at the box office.
read more

31 August, 2016 by The TZ Newswire Staff Comments Off on Brief: The SEC Collects $115.90 Per $1 Million Per Issuer Filing Amount

Brief: The SEC Collects $115.90 Per $1 Million Per Issuer Filing Amount

The SEC generates fees in a bit of a convoluted fashion.  No fault of their own, the SEC is mandated by law to set the fee based on the Commission’s projections for the fiscal year.  The regulator had some help in the methodology as the… Read More

read more